Dennis K. McBride

Dr. Dennis McBride is a veteran having over two decades of contributions in the management of Strategy Disruption for business, government, and private industries. Currently Dennis is the Chief Strategy Officer of the $ 3Billion/year Source America enterprise and also serving as Chief Strategy Officer and Senior Scientist for neuroRx-a very successful small molecule drug development corporation having operation in the U.S. (testing in Mass General, Yale, Columbia, UAB, Baylor and Tel Aviv.

EDUCATION, TRAINING, and PROFESSIONAL BACKGROUND

Ph.D., M.S., B.S., Experimental, Differential, Quantitative Psychology, The University of Georgia

M.S., Systems Management, Viterbi School of Engineering, University of Southern California

MPA/M.S. (transfer from MBA program, Temple University), Public Administration, Troy State University

M.A. (program 2016--) Applied Economics, American University

Naval Officer (Retired as O-6), Naval Aerospace Experimental Psychologist; Senior Executive 4 (Director, Center for Technology & National Security Policy, National Defense University); Flight Test Engineer, University of Tennessee Space Institute/Naval Test Pilot School; Blue Ocean Strategy (INSEAD); Disruptive Strategy (Harvard Business School); Management Science (GWU); Aerospace Medicine (Naval Aerospace Medical Institute); Operations Research/Human Factors Engineering (University of Michigan); Flight Simulation (MIT); Complex Adaptive Systems (Santa Fe Institute); Biostatistics (Institute of Statistics). 

PROFESSIONAL PROFILE

·        35 years experience in highly disruptive leadership, from bench scientist to current CSO at $3B enterprise

·        Developing, executing game-change strategies for business, government, not-for-profit agencies

·        Ph.D. quantitative focus, + formal training in MBA/MPA; management sciences (USC, Los Angeles)

·        Expert techniques (Harvard Business School Disruptive Strategy and Blue Ocean LOB Development)

·        Developed/provide technical research leadership for high-profile USG scientific/technology organizations, e.g.:

·        Defense Advanced Research Projects Agency (DARPA) 2 tours, 7 yr as PM, multiple, major transitions

·        Naval Research Laboratory/Office of Naval Research, Retired as Navy CAPT (O-6); Senior Executive-4

·        Led multiple National Academies/National Research Council studies of high tech/profile programs

·        Elected by faculties to full, tenured professor, in departments of engineering and psychology

·        Active in research, service, instruction; supervised 50+ Master’s and Ph.D. degree completions

·        Colleges of engineering, medicine, arts and sciences, and public policy

·        Published excess of 100 peer/technical reviewed articles, books, chapters, reviews, abstracts

·        Strategic director for 4^th largest university research park in the U.S. - $3B/y in very high-tech industry

·        Held dean level and AVP (Research) appointments; president of an R-1 university research foundation

·        Editor-in-Chief (past): Technology; Regulatory Science; Review of Policy Research

·        Currently adjunct professor, Georgetown Medical, Co-founder/Director, Regulatory Science Program

·        President Emeritus, Potomac Institute for Policy Studies (non-partisan scientific advice to Congress)

·        Continuous, intense interaction with Hill Members and staff on strategic level policy issues

·        Generated multiple focused studies for White House (including POTUS) and Agency Secretaries

·        Preparation of invited amicus curiae, including U.S. Supreme Court; expert testimony/witness

·        Co-created successful private businesses, LOBs, transitioned multiple technologies to private markets, e.g.,

·        Developed hand-held ultra-sound technology for Navy Medicine – transitioned to $4B global market

·        Developed disruptive $100M agent-based distributed simulation technologies, to $2B market globally

·        C-Suite level consultant to numerous corporations, organizations, universities (multiple references on request)

·        Disruptive management strategies-investment/LOB generation, R&D portfolio analysis/development

·        Provided direct support for municipal, county, state, regional, and federal governments; OAS, NATO

·         Serving currently as Chief Strategy Officer (and Senior/Chief Scientist) for:

·        SourceAmerica (a Congress/White House-designated Central Nonprofit Agency, Ability One Program)

·        Develop 1000’s of job choices for people with disabilities in all 57 states/territories

·        NeuroRx Pharmaceutical Corporation (Tel Aviv/Technion, Boston, New York, Virginia)

·        Strategy, funding, FDA fast-track-approved testing for disruptive psychiatric compounds